Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FD1AY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units) with a ceiling value of $4,169.59. This firm fixed-price delivery order was awarded on October 7, 2025, with an ultimate completion date of October 8, 2025. The award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Xtandi, an oncology medication, represents one of many specialized pharmaceutical products that DMS Pharmaceutical Group provides through this vehicle, which encompasses branded and generic prescription drugs, biologics, and medical consumables across multiple product categories.
Quick answers
Who was awarded contract SPE2DB26FD1AY?
SPE2DB26FD1AY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 7, 2025.
How much is contract SPE2DB26FD1AY worth?
The government has obligated $4,170 on SPE2DB26FD1AY.
Is contract SPE2DB26FD1AY an order under another contract?
Yes. SPE2DB26FD1AY is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB26FD1AY competed?
The extent of competition for SPE2DB26FD1AY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award